• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 13, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Persistent Heart Dysfunction Rare Six Months After Pediatric Inflammatory Syndrome

by
November 13, 2026
in Health
Reading Time: 2 mins read
0
Persistent Heart Dysfunction Rare Six Months After Pediatric Inflammatory Syndrome

Persistent Heart Dysfunction Rare Six Months After Pediatric Inflammatory Syndrome

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Persistent left ventricular systolic dysfunction was infrequently observed among children reassessed by echocardiography at least six months following SARS-CoV-2–associated multisystem inflammatory syndrome in children, according to a systematic review and rare-event meta-analysis. Across ten observational cohorts evaluating 432 pediatric patients who underwent late imaging, only three children experienced lingering left ventricular systolic impairment, corresponding to a crude observed proportion of 0.69 percent.

Multisystem inflammatory syndrome in children associated with SARS-CoV-2 frequently involves acute myocardial dysfunction, but the prevalence of persistent left ventricular systolic dysfunction at longer-term follow-up remained uncertain. To resolve this question, researchers conducted a comprehensive review and quantitative synthesis of observational cohort studies tracking longitudinal echocardiographic follow-up in children and adolescents younger than 21 years with SARS-CoV-2–associated condition.

The investigation prespecified persistent left ventricular systolic dysfunction as its primary endpoint, established objectively as a left ventricular ejection fraction of less than 55 percent at six months or longer after initial illness. Study-level events and population counts were extracted and standardized by using the specific number of children who completed echocardiography at or beyond the six-month mark as the endpoint-specific denominator for analysis.

To synthesize the sparse event data without introducing artificial continuity adjustments, the primary pooled prevalence was calculated using an intercept-only binomial logistic-normal generalized linear mixed model fitted directly to study-level event counts and denominators. This continuity-correction-free model yielded a pooled prevalence of 0.69 percent, with a 95 percent confidence interval spanning from 0.22 percent to 2.13 percent. The authors cautioned that because only three total events were observed across all cohorts, this model-based calculation should not be interpreted as a precise estimate of the underlying population prevalence.

Methodological sensitivity analyses highlighted the instability inherent in rare-event meta-analytic modeling. The investigators retained an originally prespecified random-effects logit model using restricted maximum likelihood estimation and Hartung–Knapp–Sidik–Jonkman confidence intervals, alongside alternative continuity corrections and transformation-based methods. These continuity-corrected sensitivity models produced pooled prevalence estimates ranging between 1.62 percent and 2.23 percent, demonstrating pronounced numerical sensitivity to how zero-event cohorts are mathematically handled.

The study concluded that while persistent ventricular dysfunction appears rare at late follow-up, the available evidence remains insufficient to determine exact population prevalence with precision. The authors noted that clinical inference is further restricted by heterogeneous follow-up schedules across studies and potential selection bias resulting from nonuniform late imaging, emphasizing the need for larger prospective cohorts with standardized long-term surveillance.

Subject of Research: Prevalence of persistent left ventricular systolic dysfunction at six months or later after pediatric multisystem inflammatory syndrome

Article Title: Persistent left ventricular systolic dysfunction at ≥6 months after SARS-CoV-2–associated MIS-C: a systematic review and rare-event meta-analysis

Article References: Shafeen, K., Al Qahtani, M., Alnajjar, A., Alam, M., Gurumurthy, K., Masala, C. G., Al Othman, W., Al Essa, N. A., Almutiri, M., Esmail, A., Al Qannas, M., & Uddin, M. S. (2026). Persistent left ventricular systolic dysfunction at ≥6 months after SARS-CoV-2–associated MIS-C: a systematic review and rare-event meta-analysis. Frontiers in Cardiovascular Medicine, 13, Article 1931919. https://doi.org/10.3389/fcvm.2026.1931919

Image Credits: AI Generated

DOI: 10.3389/fcvm.2026.1931919

Keywords: multisystem inflammatory syndrome in children, MIS-C, SARS-CoV-2, pediatric cardiology, left ventricular systolic dysfunction, echocardiography, systematic review, meta-analysis, Persistent, left, ventricular, systolic

News Source: Harold Sullivan. (November 13, 2026). Persistent Heart Dysfunction Rare Six Months After Pediatric Inflammatory Syndrome. Scienmag.

Tags: echocardiographyleftleft ventricular systolic dysfunctionMeta-analysisMIS-Cmultisystem inflammatory syndrome in childrenpediatric cardiologypersistentSARS-CoV-2systematic reviewsystolicventricular
Share12Tweet7Share2ShareShareShare1

Related Posts

Inflammatory Biomarkers Distinguish Internal Toxin Syndrome in Stable Post-PCI Patients

Inflammatory Biomarkers Distinguish Internal Toxin Syndrome in Stable Post-PCI Patients

November 13, 2026
Canine Probiotic Improves Stool Quality and Gut Microbiome in Healthy Dogs

Canine Probiotic Improves Stool Quality and Gut Microbiome in Healthy Dogs

November 13, 2026

Elevated CTI Biomarker Linked to Higher One-Year Mortality in Cardiometabolic Patients

November 13, 2026

Solar Phototherapy Effectively Treats Severe Neonatal Hyperbilirubinemia Across Nigerian Clinics

November 13, 2026

POPULAR NEWS

  • Inflammatory Biomarkers Distinguish Internal Toxin Syndrome in Stable Post-PCI Patients

    Inflammatory Biomarkers Distinguish Internal Toxin Syndrome in Stable Post-PCI Patients

    29 shares
    Share 12 Tweet 7
  • Protein Tudor-SN Promotes Mouse Reproduction by Regulating Gonadotropin Secretion

    29 shares
    Share 12 Tweet 7
  • Canine Probiotic Improves Stool Quality and Gut Microbiome in Healthy Dogs

    29 shares
    Share 12 Tweet 7
  • Elevated CTI Biomarker Linked to Higher One-Year Mortality in Cardiometabolic Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Inflammatory Biomarkers Distinguish Internal Toxin Syndrome in Stable Post-PCI Patients

Protein Tudor-SN Promotes Mouse Reproduction by Regulating Gonadotropin Secretion

Canine Probiotic Improves Stool Quality and Gut Microbiome in Healthy Dogs

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.